Literature DB >> 17431880

Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populations.

Gila Idelman1, James G Taylor, Ron Tongbai, Renee A Chen, Cynthia M Haggerty, Sven Bilke, Stephen J Chanock, Kevin Gardner.   

Abstract

Multiple variants of the vascular adhesion molecule-1 (VCAM1) promoter show increased nucleotide heterozygosity in the African American population. Using a novel transfection-based transcriptional pathway profiling method, we show that select uncommon variants are functionally hyperactive. Eight candidate VCAM1 promoter haplotypes comprising 13 previously identified SNPs were assessed for response to known mitogens. Activity was correlated with bioinformatic analysis of hyper- and hyporesponsive variants to identify the gain or loss of haplotype-specific transcription factor binding site (TFBS). Using this approach, a low frequency regulatory allele (c.-540A>G; dbSNP rs3783605:A>G), found in a hyperactive VCAM1 promoter haplotype, was shown to create a candidate binding site for ETS2 that was confirmed in vivo by chromatin immunoprecipitation. This report provides the first functional evaluation of VCAM1 promoter polymorphisms and establishes a hypothetical foundation for investigation of their role in the pathogenesis of VCAM1-associated diseases that disproportionately afflict African Americans, including thromboembolic diseases, asthma, and multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431880     DOI: 10.1002/humu.20523

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

1.  Genetic modulation of anemia severity, hemolysis level, and hospitalization rate in Angolan children with Sickle Cell Anemia.

Authors:  Isabel Germano; Brígida Santos; Mariana Delgadinho; Catarina Ginete; Pedro Lopes; Ana Paula Arez; Miguel Brito; Paula Faustino
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

2.  ICAM1 K469E and E-selectin S128R polymorphisms could predispose to increased autoantibody production and TSH suppression in Graves' disease.

Authors:  Müge Kanmaz-Özer; Semra Doğru-Abbasoğlu; Pervin Vural; Ayşenur Özderya; Berrin Karadağ; Müjdat Uysal
Journal:  Mol Biol Rep       Date:  2012-12-16       Impact factor: 2.316

3.  Transcriptional networks inferred from molecular signatures of breast cancer.

Authors:  Ron Tongbai; Gila Idelman; Silje H Nordgard; Wenwu Cui; Jonathan L Jacobs; Cynthia M Haggerty; Stephen J Chanock; Anne-Lise Børresen-Dale; Gary Livingston; Patrick Shaunessy; Chih-Hung Chiang; Vessela N Kristensen; Sven Bilke; Kevin Gardner
Journal:  Am J Pathol       Date:  2008-01-10       Impact factor: 4.307

Review 4.  Biological determinants of health disparities in multiple myeloma.

Authors:  Cheryl Jacobs Smith; Stefan Ambs; Ola Landgren
Journal:  Blood Cancer J       Date:  2018-08-28       Impact factor: 11.037

5.  Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle Control.

Authors:  Yosr Hamdi; Martin Leclerc; Martine Dumont; Stéphane Dubois; Martine Tranchant; Guy Reimnitz; Penny Soucy; Pauline Cassart; Manon Ouimet; Daniel Sinnett; M'Hamed Lajmi Lakhal Chaieb; Jacques Simard
Journal:  Genes (Basel)       Date:  2019-02-28       Impact factor: 4.096

6.  Identification of functional DNA variants in the constitutive promoter region of MDM2.

Authors:  Marie-Eve Lalonde; Manon Ouimet; Mathieu Larivière; Ekaterini A Kritikou; Daniel Sinnett
Journal:  Hum Genomics       Date:  2012-09-01       Impact factor: 4.639

7.  Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia.

Authors:  Chutima Kumkhaek; James G Taylor; Jianqiong Zhu; Carolyn Hoppe; Gregory J Kato; Griffin P Rodgers
Journal:  Br J Haematol       Date:  2008-03-03       Impact factor: 6.998

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.